Lumanity

1.2K posts

Lumanity banner
Lumanity

Lumanity

@lumanity

Our unique & agile approach equip you to thrive in an ever-changing healthcare marketplace by accelerating & optimizing access to life-changing medicines

Katılım Şubat 2022
137 Takip Edilen219 Takipçiler
Lumanity
Lumanity@lumanity·
We're just a few weeks away from the 2026 Patients as Partners in Clinical Research EU conference in London! Catch our session, “Criteria for Patient Engagement Post Clinical Research Studies” and stop by booth 17 to connect! #PatientsEU2026 #PatientEngagement #PatientAdvocacy
Lumanity tweet media
English
0
0
0
8
Lumanity
Lumanity@lumanity·
Our first vignette of our Voices of Rare Disease: Perspectives Across the Community series featured advocate İpek Badırgali. Now, we are sharing Ella Balasa’s story, offering a new perspective from the cystic fibrosis community. Hear their stories: buff.ly/4iWcEaC
Lumanity tweet media
English
1
0
0
8
Lumanity
Lumanity@lumanity·
AMCP 2026 confirmed a major shift: coverage no longer guarantees access. Payers are tightening policies, raising evidence standards, and exposing where patients drop off in the real world. Read our key takeaways from Nashville: buff.ly/qaYiCds #AMCP2026 #MarketAccess
Lumanity tweet media
English
0
0
0
11
Lumanity
Lumanity@lumanity·
Living with cystic fibrosis since early childhood and grounded in a background in science, Ella Balasa brings a perspective shaped by both lived experience and deep understanding of the care journey. Hear Ella’s story: buff.ly/4iWcEaC
Lumanity tweet media
English
1
0
0
311
Lumanity
Lumanity@lumanity·
Attending this week's British Healthcare Business Intelligence Association 2026 Annual Conference? If so, be sure to catch up with our attending experts, including Claire Mason, Megan Brown, and Chloe Ormond. #BHBIA2026 #BusinessIntelligence #HealthcareInsights
Lumanity tweet media
English
0
0
0
28
Lumanity
Lumanity@lumanity·
#ArtificialIntelligence #AI governance and oversight is vital for evidence synthesis, regulatory strategy, pricing decisions, #HTA, portfolio prioritization, and market access modeling. Learn more by checking out our article in Silicon Valleys Journal: buff.ly/CyuJ1ZG
Lumanity tweet media
English
0
1
1
23
Lumanity
Lumanity@lumanity·
At the NICE Conference 2026 it was clear that the pace of change in UK HTA is accelerating, and organizations need to be ready. Our new article reflects on key themes from the conference and the implications for companies preparing for NICE engagement. buff.ly/0A5Fm34
Lumanity tweet media
English
0
0
0
4
Lumanity
Lumanity@lumanity·
Join us for a virtual Patient Engagement Open Forum (PEOF) event as we explore the key rules of engagement for pharma-patient interactions. Register and access other patient engagement content: buff.ly/q8aTiCB #PatientEngagement #PFMD #Compliance
Lumanity tweet media
English
0
0
0
24
Lumanity
Lumanity@lumanity·
Our latest podcast addresses how Medical Affairs can move beyond data delivery to translate medical insights into strategy, strengthen cross-functional collaboration, and better support physicians and patients. Listen: buff.ly/dzRcoQc #CMO #MedicalAffairs #MedAffairs
Lumanity tweet media
English
0
0
1
30
Lumanity
Lumanity@lumanity·
Don't miss the chance to connect with Lumanity’s Emily Breislin and Hannah Kilvert at the NICE Conference 2026 next week. buff.ly/JTGIvxN
Lumanity tweet media
English
0
0
0
10
Lumanity
Lumanity@lumanity·
What MFN Really Means MFN is everywhere in today’s pricing conversations, but not all MFN definitions are created equal. Our new article breaks down the real differences behind the label. Read the full insights: buff.ly/iYXNFHA #MarketAccess #DrugPricing #MFN
Lumanity tweet media
English
0
0
0
12